• Molecular Editing in Drug Discovery: Making Peripheral and Skeletal Changes Suzanne Elvidge
    April 01, 2025
    Drug discovery often begins with high-throughput screening of large libraries to identify potential hits.
  • Falling off the Patent Cliff: Patent Expirations in 2025 and Onwards Suzanne Elvidge
    March 31, 2025
    In the early 2010s, a new phenomenon hit the pharmaceutical industry – the patent cliff.
  • Moving Forward in Translational Models Suzanne Elvidge
    March 03, 2025
    Translational medicine aims to bridge the gap between basic and clinical science. New translational models help predict drug efficacy and safety, but need collaboration.
  • Working in Rare Diseases: A Business Model Suzanne Elvidge
    February 28, 2025
    Rare diseases, by definition, affect a small population.
  • The Role of Biosimilars Suzanne Elvidge
    February 12, 2025
    Biological drugs are therapeutics that are made by living organisms or are created from cells and tissues, and include therapeutic proteins and monoclonal antibodies.
  • The Value of Streamlining Manufacturing Suzanne Elvidge
    February 12, 2025
    Drug manufacturing makes up a significant part of what it costs to develop drugs. As expenditures for ingredients, power, equipment, rent and staff increase, companies are working hard to find ways to cut outlays through streamlining.
  • Making Sense of Antisense: The Power of Gene Silencing Suzanne Elvidge
    February 11, 2025
    This article explores antisense oligonucleotides (ASOs) in gene silencing, covering their mechanism, development, applications, pros and cons, and future delivery challenges.
  • Improving the Patient Experience: Developing Patient-centric Dosage Forms Suzanne Elvidge
    February 05, 2025
    Medication non - adherence impacts many. Patient - centric drug design via simplifying dose, ease - of - taking, better packaging, and 3D - printing can boost adherence.
  • How AI Can Drive Drug Discovery Suzanne Elvidge
    November 27, 2024
    The use of artificial intelligence (AI) is growing, from banking and biodiversity to travel and transport. One of the areas where its presence is significant is healthcare.
  • Making Cell and Gene Therapy Affordable Suzanne Elvidge
    November 04, 2024
    Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
PharmaSources Customer Service